tm logo
H.F.M BY TICEBA.
ABANDONED SECTION 36

on 15 Aug 2024

Last Applicant/ Owned by

DR. CHRISTOPH GANSS

Im Bäckerfeld 269120 Heidelberg

DE

Serial Number

2116374 filed on 10th Apr 2021

Correspondent Address

NELLIGAN O'BRIEN PAYNE LLP 50 O'Connor StreetSuite 300Ottawa,

ONTARIO

CA

K1P6L2

H.F.M BY TICEBA.

Vienna Information


26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Trademark usage description

stem cells for scientific or research use; cell growth media for growing cells for scientific use pharmaceutical drugs, namely pharmaceutical drugs f Read More

Classification Information


Class [001]
Stem cells for scientific or research use; cell growth media for growing cells for scientific use


Classification kind code

11

Class [005]
Pharmaceutical drugs, namely pharmaceutical drugs for treatment of skin diseases, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical drugs for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, for the treatment of blood diseases and disorders; pharmaceutical drugs for treatment of cancer, hormone replacement therapy preparations; pharmaceutical and veterinary preparations for treatment of vertigo, migraine, nausea, vomiting, for treatment of skin diseases, wound healing, pharmaceutical and veterinary preparations for treating diabetes, antidepressants; pharmaceutical preparations for anti-aging, pharmaceutical preparations namely antibiotics, vaccines; diagnostic agents for medical purposes; preparations for medical purposes, namely, for the treatment of skin diseases, allergy medication, herbal extracts for medical use, reagents for medical use; substances for medical use, namely, for regeneration of tissue and anti-inflammation; stem cells for medical purposes; stem cells for veterinary purposes; stem cells for aesthetic purposes, namely, for ant-aging, for use in dermatology procedures; somatic stem cell therapeutics, namely, for medical therapeutic use; fibroblasts for medical purposes; fibroblasts for aesthetic purposes, namely for use in dermatology procedures; pharmaceutical implants, namely, implantable surgery bones, bone grafts, cells, bone marrow; surgical implants derived from stem cells; surgical implants derived from fibroblasts, namely, surgical implants comprised of living fibroblasts tissue cells; biological tissue for implantation, namely, implants comprising living tissues; cell growth media for growing cells for medical use; pharmaceutical preparations for tissue regeneration, namely biodegradable implants for use in guided tissue regeneration; vascular grafts for implantation; living tissue, namely, surgical implants comprised of living tissues; biotechnologically engineered tissue products, namely, cell sheets/plasters for wound healing/burns, eye lense grafts, bone grafts, biological tissue grafts, human allograft tissue


Classification kind code

11

Class [042]
Stem cell research; scientific research and development and medical research and development in the field of stem cells, vaccines and medications; scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, genetics and genetic engineering; scientific research for medical purposes in the field of stem cell therapies; medical research; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information on medical and scientific research on pharmaceutical products; biomedical research; preparation of reports relating to scientific research in the field of stem cells, vaccines and medications; research in the field of medical biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry; research and development services in the field of medical biotechnology; development of industrial processes, namely, for packaging, storage and transport of human tissue and human adult ancestral cells, engineering of industrial processes to manufacture stem cells, industrial process research in the field of regenerative medicine and tissue engineering, chemical engineering


Classification kind code

11

Class [044]
Medical services relating to the removal, treatment, processing and preservation of medical cells and human tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells.


Classification kind code

11

Mark Details


Serial Number

2116374

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 23rd Mar 2023
Agent Changed
Submitted for opposition 22
on 27th Sep 2022
Search Recorded
Submitted for opposition 20
on 27th Sep 2022
Examiner's First Report
Submitted for opposition 223
on 27th Sep 2022
Total Provisional Refusal
Submitted for opposition 256
on 25th Apr 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 24th Jun 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 23rd Jun 2021
Formalized
Submitted for opposition 1
on 23rd Jun 2021
Created
Submitted for opposition 228
on 10th Apr 2021
International Registration
Submitted for opposition 30
on 10th Apr 2021
Filed